{"id":"W4396900023","doi":"10.1016/j.semnephrol.2024.151517","title":"Oral Anticoagulation Use in Individuals With Atrial Fibrillation and Chronic Kidney Disease: A Review","year":2024,"lang":"en","type":"review","venue":"Seminars in Nephrology","topic":"Atrial Fibrillation Management and Outcomes","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Toronto; McGill University Health Centre; St. Michael's Hospital","funders":"Servier; GlaxoSmithKline; AstraZeneca; Pfizer; Bristol-Myers Squibb","keywords":"Medicine; Kidney disease; Atrial fibrillation; Stroke (engine); Renal function; Intensive care medicine; Randomized controlled trial; Population; Dialysis; Internal medicine; Apixaban; Warfarin; Rivaroxaban","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0005797702,0.0004205371,0.002056238,0.0007707797,0.00002692454,0.00004155822,0.00007334426,0.0003199616,0.00008445866],"category_scores_gemma":[0.0004265333,0.0003100231,0.0003033645,0.0009341548,0.0001059163,0.0001732057,0.0001326876,0.0003593246,0.00003832729],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002557115,"about_ca_system_score_gemma":0.0005295842,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00001683491,"about_ca_topic_score_gemma":0.00004335707,"domain_scores_codex":[0.9976221,0.0003110933,0.0008756201,0.000607805,0.0002595564,0.0003238621],"domain_scores_gemma":[0.9988865,0.0002898999,0.0002976171,0.0003437212,0.00002645794,0.0001557769],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0002049072,0.000005484864,0.1349256,0.1186873,0.0004616978,0.000290402,0.0000464746,0.00002345333,2.705865e-7,0.0005886234,0.007652367,0.7371135],"study_design_scores_gemma":[0.0009920734,0.0001683032,0.005758664,0.09070211,0.004277609,0.000064641,0.000001409321,0.0001062889,1.289257e-8,0.00007622281,0.8976013,0.0002513708],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0006024895,0.9944071,0.000004797723,0.001600131,0.0002279269,0.003034846,0.00003708282,0.0000514754,0.0000341611],"genre_scores_gemma":[0.00008186083,0.99668,0.0002765544,0.000357242,0.000940499,0.00001056034,0.001009345,0.00005937021,0.0005845676],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.8899489,"threshold_uncertainty_score":0.9999352,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.06467564797654411,"score_gpt":0.3763414898798393,"score_spread":0.3116658419032952,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}